1. Short title This Act may be cited as the Caring Recovery for Infants and Babies Act or the CRIB Act . 2. Findings Congress finds as follows: (1) Neonatal abstinence syndrome (referred to in this section as NAS ) is a group of conditions a newborn can have if the newborn was exposed to drugs, including opioids while in the womb before birth. (2) According to a report of the Government Accountability Office (referred to in this section as the GAO report ) symptoms of NAS include irritability, loud crying, stiffness, sweating, vomiting, diarrhea, poor feeding, seizures, and respiratory distress. (3) According to the GAO report, it is recommended that newborns with NAS receive a thorough evaluation and specialized and innovative treatment, when warranted. (4) According to the GAO report, there is a program gap of available treatment programs for both pregnant women and newborns with NAS. (5) According to the GAO report, newborns with NAS stayed in the hospital on average 16 days with an average hospital bill of $53,000. (6) According to GAO reports, NAS has more than quadrupled in the past decade, increasing from 1.2 per 1,000 hospital births per year in 2000 to 5.8 per 1,000 hospital births per year in 2012 and some regional studies have reported much higher incidences. (7) Addressing the treatment of infants diagnosed with NAS will take innovative, specialized, and collaborative efforts. (8) In July 2016, Congress passed, and the President signed into law, the Comprehensive Addiction and Recovery Act ( Public Law 114–198 ), which examines how infants with NAS are cared for (including available options through State Medicaid programs), assesses the different medical care models and settings to treat NAS, and prioritizes finding best practices for treating infants with NAS. 3. Medicaid State plan option to enter into provider agreements with residential pediatric recovery centers (a) State plan amendment Section 1902(a) of the Social Security Act ( 42 U.S.C. 1396a(a) ) is amended— (1) in paragraph (82), by